Native and compactly folded in-solution conformers of pepsin are revealed and distinguished by mass spectrometric ITEM-TWO analyses of gas-phase pepstatin A – pepsin complex binding strength differences

Pepsin, because of its optimal activity at low acidic pH, has gained importance in mass spectrometric proteome research as a readily available and easy-to-handle protease. Pepsin has also been study object of protein higher-order structure analyses, but questions about how to best investigate pepsin in-solution conformers still remain. We first determined dependencies of pepsin ion charge structures on solvent pH which indicated the in-solution existence of (a) natively folded pepsin (N) which by nanoESI-MS analysis gave rise to a narrow charge state distribution with an 11-fold protonated most intense ion signal, (b) unfolded pepsin (U) with a rather broad ion charge state distribution whose highest ion signal carried 25 protons, and (c) a compactly folded pepsin conformer (C) with a narrow charge structure and a 12-fold protonated ion signal in the center of its charge state envelope. Because pepsin is a protease, unfolded pepsin became its own substrate in solution at pH 6.6 since at this pH some portion of pepsin maintained a compact/native fold which displayed enzymatic activity. Subsequent mass spectrometric ITEM-TWO analyses of pepstatin A - pepsin complex dissociation reactions in the gas phase confirmed a very strong binding of pepstatin A by natively folded pepsin (N). ITEM-TWO further revealed the existence of two compactly folded in-solution pepsin conformers (Ca and Cb) which also were able to bind pepstatin A. Binding strengths of the respective compactly folded pepsin conformer-containing complexes could be determined and apparent gas phase complex dissociation constants and reaction enthalpies differentiated these from each other and from the pepstatin A - pepsin complex which had been formed from natively folded pepsin. Thus, ITEM-TWO turned out to be well suited to pinpoint in-solution pepsin conformers by interrogating quantitative traits of pepstatin A - pepsin complexes in the gas phase.

[1]  M. Glocker,et al.  Characterization of Phosphorylation-Dependent Antibody Binding to Cancer-Mutated Linkers of C2H2 Zinc Finger Proteins by Intact Transition Epitope Mapping-Thermodynamic Weak-Force Order Analysis. , 2023, Journal of the American Society for Mass Spectrometry.

[2]  M. Glocker,et al.  Intact Transition Epitope Mapping—Force Differences between Original and Unusual Residues (ITEM-FOUR) , 2023, Biomolecules.

[3]  M. Glocker,et al.  Epitope Fine Mapping by Mass Spectrometry: Investigations of Immune Complexes Consisting of Monoclonal Anti‐HpTGEKP Antibody and Zinc Finger Protein Linker Phospho‐Hexapeptides , 2022, Chembiochem : a European journal of chemical biology.

[4]  M. Glocker,et al.  Mass Spectrometric and Bio-Computational Binding Strength Analysis of Multiply Charged RNAse S Gas-Phase Complexes Obtained by Electrospray Ionization from Varying In-Solution Equilibrium Conditions , 2021, International journal of molecular sciences.

[5]  M. Glocker,et al.  Mass Spectrometric Analysis of Antibody—Epitope Peptide Complex Dissociation: Theoretical Concept and Practical Procedure of Binding Strength Characterization , 2020, Molecules.

[6]  Carla Schmidt,et al.  Native mass spectrometry-A valuable tool in structural biology. , 2020, Journal of mass spectrometry : JMS.

[7]  M. Glocker,et al.  Intact Transition Epitope Mapping - Thermodynamic Weak-force Order (ITEM - TWO). , 2020, Journal of proteomics.

[8]  M. Glocker,et al.  Epitope Ligand Binding Sites of Blood Group Oligosaccharides in Lectins Revealed by Pressure-Assisted Proteolytic Excision Affinity Mass Spectrometry , 2018, Journal of The American Society for Mass Spectrometry.

[9]  M. Glocker,et al.  Mass spectrometric epitope mapping. , 2018, Mass spectrometry reviews.

[10]  C. Jeffery Protein moonlighting: what is it, and why is it important? , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[11]  M. Glocker,et al.  Apparent activation energies of protein–protein complex dissociation in the gas–phase determined by electrospray mass spectrometry , 2017, Analytical and Bioanalytical Chemistry.

[12]  M. Glocker,et al.  Mass spectrometric characterization of protein structures and protein complexes in condensed and gas phase , 2017, European journal of mass spectrometry.

[13]  M. Glocker,et al.  Intact Transition Epitope Mapping (ITEM) , 2017, Journal of The American Society for Mass Spectrometry.

[14]  M. Glocker,et al.  A Dynamic Model of pH-Induced Protein G'e Higher Order Structure Changes derived from Mass Spectrometric Analyses. , 2016, Analytical chemistry.

[15]  M. Glocker,et al.  Mass spectrometric characterization of limited proteolysis activity in human plasma samples under mild acidic conditions. , 2015, Methods.

[16]  S. Cianférani,et al.  Towards integrative structural mass spectrometry: Benefits from hybrid approaches. , 2015, Methods.

[17]  C. Petosa,et al.  The emerging role of native mass spectrometry in characterizing the structure and dynamics of macromolecular complexes , 2015, Protein science : a publication of the Protein Society.

[18]  Y. Yu,et al.  Accessing the reproducibility and specificity of pepsin and other aspartic proteases. , 2013, Biochimica et biophysica acta.

[19]  I. Kaltashov,et al.  Mass spectrometry‐based methods to study protein architecture and dynamics , 2013, Protein science : a publication of the Protein Society.

[20]  Shibdas Banerjee,et al.  Electrospray Ionization Mass Spectrometry: A Technique to Access the Information beyond the Molecular Weight of the Analyte , 2011, International journal of analytical chemistry.

[21]  R. Yada,et al.  Dynamics of thermodynamically stable, kinetically trapped, and inhibitor-bound states of pepsin. , 2011, Biophysical journal.

[22]  A. Heck Native mass spectrometry: a bridge between interactomics and structural biology , 2008, Nature Methods.

[23]  I. Kaltashov,et al.  Do ionic charges in ESI MS provide useful information on macromolecular structure? , 2008, Journal of the American Society for Mass Spectrometry.

[24]  C. Robinson,et al.  The role of mass spectrometry in structure elucidation of dynamic protein complexes. , 2007, Annual review of biochemistry.

[25]  S. Eyles,et al.  Gas-phase interference-free analysis of protein ion charge-state distributions: detection of small-scale conformational transitions accompanying pepsin inactivation. , 2007, Analytical chemistry.

[26]  M. Przybylski,et al.  Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T. , 1996, Biochemistry.

[27]  M. Glocker,et al.  Electrospray Mass Spectrometry of Biomacromolecular Complexes with Noncovalent Interactions—New Analytical Perspectives for Supramolecular Chemistry and Molecular Recognition Processes , 1996 .

[28]  M. Glocker,et al.  Mass spectrometric approaches to molecular characterization of protein-nucleic acid interactions. , 1995, Toxicology letters.

[29]  Franz Hillenkamp,et al.  Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) of membrane proteins and non-covalent complexes , 1995 .

[30]  M. James,et al.  Crystal structure of human pepsin and its complex with pepstatin , 1995, Protein science : a publication of the Protein Society.

[31]  B. Chait,et al.  Observation of the heme-globin complex in native myoglobin by electrospray-ionization mass spectrometry , 1991 .

[32]  D. Suckau,et al.  Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. James,et al.  Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Rich,et al.  Mechanism of inhibition of pepsin by pepstatin. Effect of inhibitor structure on dissociation constant and time-dependent inhibition. , 1980, Biochemical pharmacology.

[35]  R. Workman,et al.  Pepsin inhibition by a high specific activity radioiodinated derivative of pepstatin. , 1979, Archives of biochemistry and biophysics.

[36]  T. Aoyagi,et al.  Mechanism of inhibition of pepsin by pepstatin. , 1972, The Journal of antibiotics.

[37]  T. Aoyagi,et al.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes. , 1970, The Journal of antibiotics.

[38]  D. Piper,et al.  pH stability and activity curves of pepsin with special reference to their clinical importance. , 1965, Gut.

[39]  Costel C. Darie,et al.  Advancements of Mass Spectrometry in Biomedical Research , 2019, Advances in Experimental Medicine and Biology.

[40]  Basri Gülbakan,et al.  Applying mass spectrometry to study non-covalent biomolecule complexes. , 2016, Mass spectrometry reviews.

[41]  T. Aoyagi,et al.  Mechanism of inhibition of pepsin by pepstatin. II. , 1974, The Journal of antibiotics.